首页 | 本学科首页   官方微博 | 高级检索  
     


Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
Authors:S Vincent Rajkumar  Susanna Jacobus  Natalie S Callander  Rafael Fonseca  David H Vesole  Michael E Williams  Rafat Abonour  David S Siegel  Michael Katz  Philip R Greipp
Affiliation:1. Mayo Clinic, Rochester, Minnesota, USA;2. Dana Farber Cancer Institute, Boston, MA, USA;3. University of Wisconsin, Madison, WI, USA;4. Mayo Clinic Arizona, Scottsdale, AZ, USA;5. St Vincent''s Hospital, New York, NY, USA;6. University of Virginia Health System, Charlottesville, VA, USA;7. Indiana University Simon Cancer Center, Indianapolis, IN, USA;8. Hackensack University Medical Center, Hackensack, NJ, USA;9. International Myeloma Foundation, North Hollywood, CA, USA
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号